Canada markets close in 4 hours 53 minutes

Cassava Sciences, Inc. (SAVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
87.95+3.09 (+3.64%)
As of 11:07AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close84.86
Open81.63
Bid86.81 x 1100
Ask87.20 x 1300
Day's Range80.68 - 88.63
52 Week Range2.78 - 146.16
Volume1,773,610
Avg. Volume3,634,540
Market Cap3.519B
Beta (5Y Monthly)1.14
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateAug. 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec. 13, 2012
1y Target Est116.20
  • Cassava Sciences Reports Second Quarter 2021 Financial Results
    GlobeNewswire

    Cassava Sciences Reports Second Quarter 2021 Financial Results

    - Conference Call Today at 9 a.m. ET -AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the second quarter ended June 30, 2021. Net loss for the second quarter ended June 30, 2021, was $5.1 million, or $0.13 per share, compared to a net loss of $1.1 million, or $0.05 per share, for the same period in 2020. Net cash used in operations was $7.4 million

  • 5 Ultra-Popular Stocks to Avoid Like the Plague in August
    Motley Fool

    5 Ultra-Popular Stocks to Avoid Like the Plague in August

    Movie theater chain and chief meme stock AMC Entertainment (NYSE: AMC) is a liable to be a fixture on this monthly list until it either resolves its operating inefficiencies or retraces another 85% -- whichever comes first. The premise for avoiding AMC is simple: The math doesn't make sense. Although AMC was able to raise in the neighborhood of $2.2 billion in capital, it's still contending with over $5.4 billion in debt, as of the end of March, has $473 million in deferred rental obligations, and is dealing with multiple billions of dollars in remaining lease obligations.

  • Cassava Sciences Announces Conference Call for Second Quarter Financial Results
    GlobeNewswire

    Cassava Sciences Announces Conference Call for Second Quarter Financial Results

    - Call-in on Tuesday, August 3rd at 9 a.m. ET -AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, will release financial results for the period ending June 30, 2021 on Tuesday, August 3, 2021 before the market opens, followed by a conference call. Remi Barbier, President & CEO, and Eric Schoen, Chief Financial Officer, will host a conference call to review financial results and to preview the Company’s g